Projects per year
Fingerprint
Dive into the research topics where Aaron Mansfield is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy
Cunningham, B. B. T., Mansfield, A. & Wang, X. X.
8/1/23 → 7/31/24
Project: Research project
-
-
Degron Disruption in Small Cell Lung Cancer
Congressionally Directed Medical Research Programs
1/1/21 → …
Project: Research project
-
Blood-based biomarker of therapeutic efficacy for mesothelioma
7/10/20 → 6/30/22
Project: Research project
-
A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors
Barham, W., Hsu, M., Liu, X., Harrington, S. M., Hirdler, J. B., Gicobi, J. K., Zhu, X., Zeng, H., Pavelko, K. D., Yan, Y., Mansfield, A. S. & Dong, H., Jan 1 2023, In: ImmunoHorizons. 7, 1, p. 125-139 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Checkpoint blockade in unresectable pleural mesothelioma: Event horizon for multimodal therapy
Ripley, R. T., Mansfield, A. S., Sepesi, B., Bueno, R. & Burt, B. M., Jan 2023, In: Journal of Thoracic and Cardiovascular Surgery. 165, 1, p. 364-368 5 p.Research output: Contribution to journal › Editorial › peer-review
-
Dynamics and survival associations of T cell receptor clusters in patients with pleural mesothelioma treated with immunotherapy
Desai, A. P., Kosari, F., Disselhorst, M., Yin, J., Agahi, A., Peikert, T., Udell, J., Johnson, S. H., Smadbeck, J., Murphy, S., Karagouga, G., McCune, A., Schaefer-Klein, J., Borad, M. J., Cheville, J., Vasmatzis, G., Baas, P. & Mansfield, A., Jun 6 2023, In: Journal for ImmunoTherapy of Cancer. 11, 6, e006035.Research output: Contribution to journal › Article › peer-review
Open Access -
Epigenomics may begin to explain in vitro differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancer
El Khoury, L. Y., Lin, W. H., Smadbeck, J. B., Barrett, M. T., Sadeghian, D., Mccune, A. F., Karagouga, G., Cheville, J. C., Harris, F. R., Kinsella, L. M., Feathers, R. W., Schafer Klein, J. L., Walther-Antonio, M. R. S., Johnson, S. H., Penheiter, A. R., Cucinella, G., Schivardi, G., Bhagwate, A., Borad, M. J., Mansfield, A. S., & 6 others, Mar 1 2023, In: Epigenomics. 15, 5, p. 283-292 10 p.Research output: Contribution to journal › Article › peer-review
-
Perioperative Immune Checkpoint Inhibition in Early-Stage Non-Small Cell Lung Cancer: A Review
Desai, A. P., Adashek, J. J., Reuss, J. E., West, H. & Mansfield, A. S., Jan 19 2023, In: JAMA Oncology. 9, 1, p. 135-142 8 p.Research output: Contribution to journal › Review article › peer-review